Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
BMC Vet Res ; 14(1): 68, 2018 Mar 05.
Article in English | MEDLINE | ID: mdl-29506524

ABSTRACT

BACKGROUND: Crossed beaks have been reported to occur in Appenzeller Barthuhn, a local Swiss chicken breed. The assumed causes for this beak deformity which are also seen in other bird species including domestic chickens, range from environmental influences to genetic factors. The aim of this project was to characterize the prevalence, the phenotype, and the underlying genetics of crossed beaks in Appenzeller Barthuhn chickens. RESULTS: The estimated prevalence of 7% crossed beaks in Appenzeller Barthuhn was significantly higher compared to two other local Swiss chicken breeds. A breeding trial showed significantly higher prevalence of offspring with deformed beaks from mating of affected parents compared to mating of non-affected parents. Examination of 77 Appenzeller Barthuhn chickens with crossed beaks showed a variable phenotype presentation. The deviation of the beak from the median plane through the head ranged from 1° to 61°. In more than 60% of the cases, the upper and lower beak were bent in the same direction, whereas the remaining cases showed different forms of crossed beaks. Computed tomographic scans and bone maceration of the head of two chickens with crossed beaks revealed that the maxilla and the mandibula were affected, while other parts of the skull appeared to be normal. The gene LOC426217, a member of the keratin family, was postulated as a candidate gene for beak deformity in domestic chickens. Sequencing of the coding region revealed two significantly associated synonymous variants for crossed beaks in Appenzeller Barthuhn chickens. A genome-wide association study and a comparative analysis of runs of homozygosity based on high-density SNP array genotyping data of 53 cases and 102 controls showed no evidence of association. CONCLUSIONS: The findings suggest a hereditary cause of crossed beaks in Appenzeller Barthuhn chickens. However, the observed variation in the phenotype, together with the inconclusive molecular genetic results indicates the need for additional research to unravel the genetic architecture of this beak deformity.


Subject(s)
Beak/abnormalities , Chickens/abnormalities , Animals , Female , Genetic Association Studies/veterinary , Keratins/genetics , Male , Polymorphism, Single Nucleotide/genetics , Prevalence , Species Specificity , Switzerland/epidemiology
2.
Dermatology ; 222(1): 81-6, 2011 Feb.
Article in English | MEDLINE | ID: mdl-21196704

ABSTRACT

BACKGROUND: Epidermodysplasia verruciformis Lewandowsky-Lutz (EV) is a rare genodermatosis, characterised by development of numerous verrucous skin lesions caused by specific genotypes of human papillomaviruses belonging to the ß-papillomavirus genus. The EV loci were mapped to chromosome 2p21-p24 (EV2) and 17q25 (EV1). On chromosome 17, 2 adjacent related genes--EVER1/TMC6 and EVER2/TMC8--were identified. We reinvestigated 2 patients originally described by Wilhelm Lutz in 1946 with the aim to document the natural course of the disease and confirm his diagnosis. METHODS: PCR fragments specific for exons with short flanking intron sequences of EVER1/TMC6 and EVER2/TMC8 genes from patients' DNA were amplified using sequence information. The single-nucleotide polymorphism (SNP) rs7208422 was studied, using restriction fragment length polymorphism analysis. RESULTS: In the index patient, we identified a homozygous TT genotype in exon 8 of the EVER2/TMC8 gene (c.917A→T, p.N306I). The same mutation could thereafter be detected in her sister from paraffin-embedded skin. CONCLUSION: We have followed one of the first patients described with EV in Basel, Switzerland, in 1930 until today and demonstrated the TT genotype (SNP rs7208422) in the EVER2/TMC8 gene in this index patient and her sister. The results underline the possible relevance of SNP rs7208422 by influencing the susceptibility to ß-papillomaviruses and their oncogenic potential.


Subject(s)
Betapapillomavirus , Carcinoma/virology , Chromosomes, Human, Pair 17 , Epidermodysplasia Verruciformis/genetics , Skin Neoplasms/virology , Aged, 80 and over , Carcinoma/genetics , DNA Mutational Analysis , Epidermodysplasia Verruciformis/virology , Exons , Female , Genetic Predisposition to Disease , Humans , Mutation , Polymerase Chain Reaction , Polymorphism, Restriction Fragment Length , Polymorphism, Single Nucleotide , Siblings , Skin Neoplasms/genetics
3.
Adv Exp Med Biol ; 624: 283-95, 2008.
Article in English | MEDLINE | ID: mdl-18348464

ABSTRACT

Skin cancers, i.e., basal cell carcinoma (BCC), squamous cell carcinoma (SCC) and melanoma, belong to the most frequent tumors. Their formation is based on constitutional and/or inherited factors usually combined with environmental factors, mainly UV-irradiation through long term sun exposure. UV-light can randomly induce DNA damage in keratinocytes, but it can also mutate genes essential for control and surveillance in the skin epidermis. Various repair and safety mechanisms exist to maintain the integrity of the skin epidermis. For example, UV-light damaged DNA is repaired and if this is not possible, the DNA damaged cells are eliminated by apoptosis (sunburn cells). This occurs under the control of the p53 suppressor gene. Fas-ligand (FasL), a member of the tumor necrosis superfamily, which is preferentially expressed in the basal layer of the skin epidermis, is a key surveillance molecule involved in the elimination of sunburn cells, but also in the prevention of cell transformation. However, UV light exposure downregulates FasL expression in keratinocytes and melanocytes leading to the loss of its sensor function. This increases the risk that transformed cells are not eliminated anymore. Moreover, important control and surveillance genes can also be directly affected by UV-light. Mutation in the p53 gene is the starting point for the formation of SCC and some forms of BCC. Other BCCs originate through UV light mediated mutations of genes of the hedgehog signaling pathway which are essential for the maintainance of cell growth and differentiation. The transcription factor Gli2 plays a key role within this pathway, indeed, Gli2 is responsible for the marked apoptosis resistance of the BCCs. The formation of malignant melanoma is very complex. Melanocytes form nevi and from the nevi melanoma can develop through mutations in various genes. Once the keratinocytes or melanocytes have been transformed they re-express FasL which may allow the expanding tumor to evade the attack of immune effector cells. FasL which is involved in immune evasion or genes which govern the apoptosis resistance, e.g., Gli2 could therefore be prime targets to prevent tumor formation and growth. Attempts to silence these genes by RNA interference using gene specific short interfering RNAs (siRNAs) or short hairpin RNAs (shRNAs) have been functionally successful not only in tissue cultures and tumor tissues, but also in a mouse model. Thus, siRNAs and/or shRNAs may become a novel and promising approach to treat skin cancers at an early stage.


Subject(s)
Apoptosis , Carcinoma, Basal Cell/etiology , Carcinoma, Squamous Cell/etiology , Melanoma/etiology , Skin Neoplasms/etiology , Animals , Carcinoma, Basal Cell/pathology , Carcinoma, Squamous Cell/pathology , Cell Transformation, Neoplastic , Humans , Melanoma/pathology , Mice , Skin Neoplasms/pathology
4.
Int J Cancer ; 122(1): 50-6, 2008 Jan 01.
Article in English | MEDLINE | ID: mdl-17721996

ABSTRACT

Basal cell carcinoma (BCC) belongs worldwide to the most frequent malignancy among Caucasians. The understanding of the molecular mechanisms of BCC formation, which is a prerequisite for the development of efficient new therapies, is still incomplete. The formation of sporadic BCCs in the skin is associated with uncontrolled hedgehog signaling, and the transcription factor Gli2 has been identified as a key mediator or effector of this signaling. There is indication in the literature that preventing Gli2 function may inhibit BCC formation and growth in vivo; however, the mechanism is unclear and difficult to study in humans. Therefore, we used a mouse tumor allograft model to investigate the role of Gli2 in tumor formation. A constitutively Gli2 expressing mouse tumor cell line was stably transfected with Gli2-specific shRNA to induce Gli2 gene silencing or with control shRNA. Injecting the Gli2 gene silenced cells into nude mice for tumor formation we detected a strongly retarded tumor growth compared with control tumor cells. Investigating the mechanisms, we found that Gli2 gene silencing has led to the disruption of the tumor structure as demonstrated by staining tumor sections with hematoxylin. Two main reasons for the tumor destruction were identified. We found that apoptosis was markedly increased while vascularization was strongly decreased in these tumors. Thus, important functions of the transcription factor Gli2 in this tumor model are the prevention of apoptosis and the promotion of microvascularization.


Subject(s)
Carcinoma, Basal Cell/genetics , Gene Silencing , Kruppel-Like Transcription Factors/genetics , Skin Neoplasms/genetics , Animals , Apoptosis , Carcinoma, Basal Cell/metabolism , Carcinoma, Basal Cell/pathology , HeLa Cells , Humans , In Situ Hybridization , In Situ Nick-End Labeling , Kruppel-Like Transcription Factors/metabolism , Male , Mice , Mice, Nude , Skin Neoplasms/metabolism , Skin Neoplasms/pathology , Tumor Cells, Cultured , Zinc Finger Protein Gli2
5.
Immunol Lett ; 100(1): 68-72, 2005 Aug 15.
Article in English | MEDLINE | ID: mdl-16054233

ABSTRACT

Long-term ultraviolet-light (UV) exposure of human skin epidermis is associated with an increased risk for the development of skin cancers, such as melanoma, basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). UV radiation not only induces DNA damage in epidermal cells, it also interferes with skin homeostasis, which is maintained by a unique distribution pattern of apoptosis-inducing and -preventing molecules. If the DNA damage is not repaired or the damaged cells are not eliminated by apoptosis, the consequence can be cell transformation, uncontrolled proliferation and eventually skin tumor formation. An important "repair" gene is the p53 suppressor gene. Excessive UV exposure can mutate the p53 gene leading to the loss of its repair function and thus apoptosis resistance of the DNA-damaged cell. For BCC formation an additional pathway has been identified. Mutation of genes of the Hedgehog signaling pathway evokes the downregulation of apoptotic genes and upregulation of anti-apoptotic genes preventing the elimination of damaged cells. In addition, BCC and SCC strongly express the apoptosis-inducing Fas-ligand (FasL) which may help the tumor to escape the attack of immune effector cells. Silencing the genes involved in tumor formation by RNA interference might become a promising new approach to treat skin tumors.


Subject(s)
Apoptosis , Carcinoma, Basal Cell/metabolism , Carcinoma, Squamous Cell/metabolism , Gene Expression Regulation, Neoplastic/radiation effects , Signal Transduction/radiation effects , Skin Neoplasms/metabolism , Ultraviolet Rays/adverse effects , Animals , Apoptosis/genetics , Carcinoma, Basal Cell/genetics , Carcinoma, Basal Cell/therapy , Carcinoma, Squamous Cell/genetics , Carcinoma, Squamous Cell/therapy , DNA Damage/genetics , DNA Damage/radiation effects , Fas Ligand Protein , Gene Expression Regulation, Neoplastic/genetics , Hedgehog Proteins , Humans , Membrane Glycoproteins/biosynthesis , Membrane Glycoproteins/genetics , Mice , Mutation , Signal Transduction/genetics , Skin Neoplasms/genetics , Skin Neoplasms/therapy , Trans-Activators/genetics , Trans-Activators/metabolism , Tumor Suppressor Protein p53/genetics , Tumor Suppressor Protein p53/metabolism
6.
J Biol Chem ; 278(37): 35373-83, 2003 Sep 12.
Article in English | MEDLINE | ID: mdl-12815049

ABSTRACT

Using a stage-specific cDNA library from Plasmodium falciparum we have identified a gene coding for a novel histidine-rich protein (MAHRP-1). The gene is exclusively transcribed during early erythrocyte stages and codes for a small transmembrane protein. The C-terminal region contains a polymorphic stretch of histidine-rich repeats. Fluorescence microscopy studies using polyclonal mouse sera revealed that MAHRP-1 is located at the Maurer's clefts, which represent parasite-induced structures within the cytosol of infected erythrocytes. Biochemical studies showed that recombinant MAHRP-1 binds the toxic hemoglobin degradation product, ferriprotoporphyrin (FP) with a submicromolar dissociation constant and a stoichiometry determined by the number of DHGH motifs. The bound FP has increased peroxidase-like activity and is 10-fold more susceptible to H2O2-induced degradation compared with unbound FP. These properties of MAHRP-1 suggest it may play a protective role against oxidative stress, and its location at the Maurer's clefts suggests a function in promoting the correct trafficking of exported proteins, such as P. falciparum erythrocyte membrane protein-1.


Subject(s)
Carrier Proteins/genetics , Erythrocytes/parasitology , Hemin/metabolism , Organelles/metabolism , Plasmodium falciparum/genetics , Polymorphism, Genetic , Protozoan Proteins , Amino Acid Sequence , Animals , Base Sequence , Carrier Proteins/chemistry , Carrier Proteins/metabolism , DNA Primers , DNA, Protozoan/genetics , Membrane Proteins , Mice , Molecular Sequence Data , Plasmodium falciparum/chemistry , Plasmodium falciparum/cytology , Plasmodium falciparum/metabolism , Recombinant Proteins/chemistry , Recombinant Proteins/metabolism , Restriction Mapping , Sequence Alignment , Sequence Homology, Amino Acid , Solubility , Swine
SELECTION OF CITATIONS
SEARCH DETAIL
...